Загрузка...
Calcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteers
PURPOSE: Nilotinib is a second-generation oral tyrosine kinase inhibitor (TKI) with superior efficacy compared with imatinib mesylate in the treatment of chronic phase chronic myelogenous leukemia (CML). Calcium carbonate is commonly used as a source of calcium supplementation or as antacid to ameli...
Сохранить в:
| Главные авторы: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3818249/ https://ncbi.nlm.nih.gov/pubmed/24036846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2283-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|